Compounds > oxolinic acid

oxolinic acid and amsacrine

oxolinic acid has been researched along with amsacrine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeMarini, DM; Lawrence, BK2
Huff, AC; Kreuzer, KN1
Jo, K; Topal, MD1
Chang, C; Freudenreich, CH; Kreuzer, KN1
Kreuzer, KN; O'Reilly, EK1

Other Studies

6 other study(ies) available for oxolinic acid and amsacrine

ArticleYear
Prophage induction by DNA topoisomerase II poisons and reactive-oxygen species: role of DNA breaks.
    Mutation research, 1992, Volume: 267, Issue:1

    Topics: Amsacrine; Azides; Bacteriophage lambda; Dactinomycin; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Ellipticines; Escherichia coli; Free Radicals; Hydrogen Peroxide; Lysogeny; Nalidixic Acid; Novobiocin; Oxolinic Acid; Oxygen; Paraquat; Sodium Azide; SOS Response, Genetics; Teniposide; Topoisomerase II Inhibitors; Virus Replication

1992
Evidence for a common mechanism of action for antitumor and antibacterial agents that inhibit type II DNA topoisomerases.
    The Journal of biological chemistry, 1990, Nov-25, Volume: 265, Issue:33

    Topics: Amsacrine; Antineoplastic Agents; Escherichia coli; Kinetics; Oxolinic Acid; Plasmids; T-Phages; Topoisomerase II Inhibitors

1990
Mutagenicity of topoisomerase-active agents in bacteriophage T4.
    Teratogenesis, carcinogenesis, and mutagenesis, 1988, Volume: 8, Issue:5

    Topics: Amsacrine; Dactinomycin; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Ellipticines; Mutation; Nalidixic Acid; Novobiocin; Oxolinic Acid; T-Phages

1988
Changing a leucine to a lysine residue makes NaeI endonuclease hypersensitive to DNA intercalative drugs.
    Biochemistry, 1996, Aug-06, Volume: 35, Issue:31

    Topics: Amsacrine; Antineoplastic Agents; Binding Sites; Daunorubicin; Deoxyribonuclease EcoRI; Deoxyribonucleases, Type II Site-Specific; DNA Nucleotidyltransferases; DNA Topoisomerases, Type I; Ellipticines; Enzyme Inhibitors; Integrases; Intercalating Agents; Kinetics; Lysine; Nalidixic Acid; Novobiocin; Oxolinic Acid; Point Mutation; Recombinant Proteins; Recombinases; Topoisomerase I Inhibitors

1996
Mutations of the bacteriophage T4 type II DNA topoisomerase that alter sensitivity to antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide and an antibacterial quinolone.
    Cancer research, 1998, Mar-15, Volume: 58, Issue:6

    Topics: Amino Acid Sequence; Amsacrine; Antineoplastic Agents; Bacteriophage T4; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Enzyme Inhibitors; Oxolinic Acid; Point Mutation; Structure-Activity Relationship; Topoisomerase II Inhibitors

1998
A unique type II topoisomerase mutant that is hypersensitive to a broad range of cleavage-inducing antitumor agents.
    Biochemistry, 2002, Jun-25, Volume: 41, Issue:25

    Topics: Amino Acid Sequence; Amino Acid Substitution; Amsacrine; Antineoplastic Agents; Bacteriophage T4; Binding Sites; DNA Damage; DNA Topoisomerases, Type II; DNA, Superhelical; Ellipticines; Enzyme Inhibitors; Filtration; Glycine; Mitoxantrone; Molecular Sequence Data; Oxolinic Acid; Podophyllotoxin; Point Mutation; Topoisomerase II Inhibitors; Valine

2002